Tandem Therapeutics AG

Private

SchlierenHealthcare & Life Scienceshttps://tandem-tx.com/

Last Round

Grant

Jun 19, 2024

Total Funding Raised

$1.25M

Company Overview

Tandem Therapeutics AG is a biotechnology company that develops peptide drug conjugates to precision-target the extracellular matrix for the treatment of fibrotic diseases and fibrotic cancers.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug discoverypeptide therapeuticsbiopharmamatrix targeting peptidesMTPprecision medicinepeptide drug conjugatesfibrotic diseaseoncologydrug delivery platformextracellular matrix biologybiotech startupdrug pipelinetherapeutic resistance

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Tandem Therapeutics AG Comps

Public and private peers based on sector, stage, and business model.

Tandem Therapeutics AG comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Tandem Therapeutics AG Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Jun 19, 2024
Grant	Sep 1, 2023
Convertible Debt	Feb 24, 2023

View all Funding Rounds

Key People

Founding team and executive leadership

Mamta Chabria

Co-Founder & CEO

Founding Team

Tandem Therapeutics AG Investors

Notable investors and investment history

Tandem Therapeutics AG investors
Investor	Rounds
W.A. de Vigier Foundation	Grant
Innosuisse	Grant
Venture Kick	Convertible Debt

View all Investors

Tandem Therapeutics AG Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Tandem Therapeutics AG Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Tandem Therapeutics AG's valuation, stock price, and market status.

Firmographic Details

HeadquartersSchlieren

Employee Range4

Year Founded2023

Last FundingJun 19, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.